Boehringer Ingelheim Updates Phase III CONNEX Clinical Program in Schizophrenia
Schizophrenia | Iclepertin | Phase III CONNEX | Boehringer Ingelheim | Clinical program design, endpoints, and progress in antipsychotic development.
We've collected the latest key neuroscience data releases, FDA announcements, and market activity for you.
Giving neuroscience decision-makers a front-row seat to real-time, unbiased opinions and insights from an international panel of expert Thought Leaders.
With thousands of updates occurring every year, Neuroscience ACCUMIN provides clear, timely, expert-driven guidance on what is impactful to inform strategic decision-making.
3,000+ currently investing in CNS product development
6,700 products with 1,350 unique mechanisms of action for CNS indications
15,000+ ongoing clinical trials involving CNS indications
See more Impact Score ratings and reactions with our Impact Archive
A curated collection of concise summaries and contextual backgrounds for significant neuroscience research.
Schizophrenia | Iclepertin | Phase III CONNEX | Boehringer Ingelheim | Clinical program design, endpoints, and progress in antipsychotic development.
Press Release| Neurocrine Biosciences | R&D transformation news showing innovation across neuroscience and endocrinology, including pipeline updates...
PD | Buntanetap | Annovis Bio | Phase 3 data show amyloid co-pathology in Parkinson’s linked to faster decline reversed with treatment; biomarkers...
See more Impact Score ratings and reactions with our Impact Archive
Enduring archive of discussion summaries and output from previous Congress Highlights sessions.
.webp?width=600&height=600&name=home_hero_image%20(77).webp)
Curious about joining us in person? You can find all of our planned, in-person neuroactivities from your member portal.
Dates and times for upcoming sessions
Locations and directions
Descriptions of each activity and what to expect
Any registration or RSVP details you’ll need
Whether you’re new to AccuminDesk or a returning participant, this is the best place to stay up to date on everything happening face-to-face.